116 related articles for article (PubMed ID: 1139938)
1. Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women.
Bhatnagar S; Srivastava UK; Takkar D; Chandra VL; Hingorani V; Laumas KR
Contraception; 1975 May; 11(5):505-21. PubMed ID: 1139938
[TBL] [Abstract][Full Text] [Related]
2. Contraceptive efficacy of norethindrone acetate (ENTA) implant: its release rate and fertility potential.
Shahani SM; Kulkarni PP; Laumas KR
J Obstet Gynaecol India; 1983 Feb; 33(1):16-20. PubMed ID: 12265592
[TBL] [Abstract][Full Text] [Related]
3. Long-term contraception by a single silastic implant-D containing norethindrone acetate in women: a clinical evaluation.
Takkar D; Anandalaxmi PN; Chandra VL; Bhatnagar S; Yadav HS; Laumas KR; Hingorani V; Krishna U; Mandleker A; Purandare VN; Goel V; Adatia A; Virker KD
Contraception; 1978 Apr; 17(4):341-54. PubMed ID: 648156
[TBL] [Abstract][Full Text] [Related]
4. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR
Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011
[TBL] [Abstract][Full Text] [Related]
5. Long-term contraception by steroid releasing implants. VI. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate.
Hillier SG; Jha P; Griffiths K; Laumas KR
Contraception; 1977 Apr; 15(4):473-88. PubMed ID: 880821
[TBL] [Abstract][Full Text] [Related]
6. Contraceptive effectiveness of Silastic implants containing the progestin R-2323.
Coutinho EM; Da Silva AR; Carreira CM; Chaves MC; Adeodato Filho J
Contraception; 1975 Jun; 11(6):625-35. PubMed ID: 1137935
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of norethindrone in women with a single silastic implant.
Goyal V; Joshi UM; Naik VK
Contraception; 1978 Apr; 17(4):375-82. PubMed ID: 648158
[TBL] [Abstract][Full Text] [Related]
8. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
9. Hormonal implants: contraception for a new century.
Darney PD
Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
[TBL] [Abstract][Full Text] [Related]
10. Subdermal norethindrone pellets -- a method for contraception?
Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with implant contraception.
Coutinho E
Contraception; 1978 Oct; 18(4):411-27. PubMed ID: 720074
[TBL] [Abstract][Full Text] [Related]
12. NORPLANT contraceptive implants advancing.
Segal SJ
Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
[TBL] [Abstract][Full Text] [Related]
13. One year contraception with a single subdermal implant containing nomegestrol acetate (Uniplant).
Coutinho EM
Contraception; 1993 Jan; 47(1):97-105. PubMed ID: 8436005
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable norethindrone (NET:cholesterol) contraceptive implants: phase II-A: a clinical study in women.
Singh M; Saxena BB; Raghubanshi RS; Ledger WJ; Harman SM; Leonard RJ
Contraception; 1997 Jan; 55(1):23-33. PubMed ID: 9013058
[TBL] [Abstract][Full Text] [Related]
15. Contraceptive efficacy, pharmacokinetics, and safety of Annuelle biodegradable norethindrone pellet implants.
Raymond EG; Singh M; Archer DF; Saxena BB; Baker J; Cole D
Fertil Steril; 1996 Dec; 66(6):954-61. PubMed ID: 8941061
[TBL] [Abstract][Full Text] [Related]
16. Effects of a single contraceptive Silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years.
Barbosa I; Coutinho E; Hirsch C; Ladipo O; Olsson SE; Ulmsten U
Fertil Steril; 1996 Apr; 65(4):724-9. PubMed ID: 8654629
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate.
Singh H; Uniyal JP; Jha P; Takker D; Murguesan K; Hingorani V; Laumas KR
Acta Endocrinol (Copenh); 1982 Feb; 99(2):302-8. PubMed ID: 7058686
[TBL] [Abstract][Full Text] [Related]
18. Contraceptive implants.
Ladipo O; Coutinho EM
Curr Opin Obstet Gynecol; 1994 Dec; 6(6):564-9. PubMed ID: 7893965
[TBL] [Abstract][Full Text] [Related]
19. Endometrial histology and progesterone levels in women using norethindrone acetate implants for contraception.
Takkar D; Jeyaseelan S; Kinra G; Laumas KR; Hingorani V
Contraception; 1978 Feb; 17(2):103-13. PubMed ID: 630880
[TBL] [Abstract][Full Text] [Related]
20. Long-term administration of norethindrone in fertility control.
Rice-wray E; Schulz-contreras M; Guerrero I; Aranda-rosell A
JAMA; 1962 May; 180(5):355-8. PubMed ID: 12275504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
